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CmeR Functions as a Transcriptional Repressor for the Multidrug Efflux
Pump CmeABC in Campylobacter jejuni
Abstract
CmeABC, a resistance-nodulation-division (RND) type of efflux pump, contributes to Campylobacter
resistance to a broad spectrum of antimicrobial agents and is also essential for Campylobacter colonization of
the animal intestinal tract by mediation of bile resistance. As one of the main systems for Campylobacter
adaptation to different environments, CmeABC is likely subject to control by regulatory elements. We
describe the identification of a transcriptional repressor for CmeABC. Insertional mutagenesis of cmeR, an
open reading frame immediately upstream of the cmeABC operon, resulted in overexpression of cmeABC, as
determined by transcriptional fusion (PcmeABC-lacZ) and immunoblotting with CmeABC-specific antibodies.
Overexpression of the efflux pump was correlated with a moderate increase in the level of resistance of the
cmeR mutant to several antimicrobials. In vitro, recombinant CmeR bound specifically to the promoter region
of cmeABC, precisely, to the inverted repeat sequences in the cmeABC promoter. A single nucleotide deletion
between the two half sites of the inverted repeat reduced the level of CmeR binding to the promoter sequence
and resulted in overexpression of cmeABC. Together, these findings indicate that cmeR encodes a
transcriptional repressor that directly interacts with the cmeABC promoter and modulates the expression of
cmeABC. Mutation either in CmeR or in the inverted repeat impedes the repression and leads to enhanced
production of the MDR efflux pump.
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CmeABC, a resistance-nodulation-division (RND) type of efflux pump, contributes to Campylobacter resis-
tance to a broad spectrum of antimicrobial agents and is also essential for Campylobacter colonization of the
animal intestinal tract by mediation of bile resistance. As one of the main systems for Campylobacter adaptation
to different environments, CmeABC is likely subject to control by regulatory elements. We describe the iden-
tification of a transcriptional repressor for CmeABC. Insertional mutagenesis of cmeR, an open reading frame
immediately upstream of the cmeABC operon, resulted in overexpression of cmeABC, as determined by tran-
scriptional fusion (PcmeABC-lacZ) and immunoblotting with CmeABC-specific antibodies. Overexpression of the
efflux pump was correlated with a moderate increase in the level of resistance of the cmeR mutant to several
antimicrobials. In vitro, recombinant CmeR bound specifically to the promoter region of cmeABC, precisely, to
the inverted repeat sequences in the cmeABC promoter. A single nucleotide deletion between the two half sites
of the inverted repeat reduced the level of CmeR binding to the promoter sequence and resulted in overex-
pression of cmeABC. Together, these findings indicate that cmeR encodes a transcriptional repressor that di-
rectly interacts with the cmeABC promoter and modulates the expression of cmeABC. Mutation either in CmeR
or in the inverted repeat impedes the repression and leads to enhanced production of the MDR efflux pump.
As a general and important mechanism for antimicrobial
resistance, multidrug efflux systems (often named MDR pumps)
contribute significantly to the intrinsic and acquired resistance
to antibiotics in bacterial organisms (37, 40, 46). In addition to
being key players in antibiotic resistance, MDR pumps also
facilitate bacterial adaptation to deleterious environments
where toxic compounds or metabolites are present. In bacteria,
expression of MDR efflux pumps is usually controlled by tran-
scriptional regulators that either repress or activate the tran-
scription of the MDR efflux genes (14, 37, 40). Many of these
regulators are local repressors that directly interact with the
promoter regions of MDR efflux genes or operons. For exam-
ple, repressors AcrR (Escherichia coli), QacR (Staphylococcus
aureus), MtrR (Neisseria gonorrhoeae), and MexR (Pseudomo-
nas aeruginosa) bind specifically to the promoter sequences of
acrAB, qacA, mtrCDE, and mexAB, respectively, thereby inhib-
iting the expression of the corresponding MDR efflux gene(s)
(9, 12, 17, 27). Mutations in the repressors or repressor-binding
sequences impede the repression and result in overexpression
of efflux pumps, which consequently increases bacterial resis-
tance to structurally unrelated antimicrobial agents (9, 12, 16,
38, 42, 48). Recently, two-component systems were also found
to be involved in the regulation of bacterial MDR pumps (3,
10, 33, 34). These examples illustrate the complexity and di-
versity of the regulatory mechanisms for bacterial MDR efflux
pumps.
Campylobacter jejuni is the leading bacterial cause of human
food-borne enteritis in many industrialized countries (11) and
has become increasingly resistant to antimicrobials, compro-
mising the effectiveness of antibiotic treatments (8, 44, 45, 53).
One of the mechanisms used by Campylobacter for antimicro-
bial resistance is the CmeABC efflux system, a resistance-
nodulation-division (RND) type of efflux pump recently iden-
tified in C. jejuni (24, 39). This efflux pump system consists of
three members, including an outer membrane protein (CmeC),
an inner membrane drug transporter (CmeB), and a periplas-
mic fusion protein (CmeA). These three proteins are encoded
by a three-gene operon (cmeABC) and function together to
form a membrane channel that extrudes toxic substrates di-
rectly out of Campylobacter cells (24). CmeABC contributes
significantly to the intrinsic and acquired resistance of Campy-
lobacter to structurally diverse antimicrobials (24, 26, 39). In
addition, CmeABC plays a key role in bile resistance and is
essential for Campylobacter growth in bile-containing media
and colonization of the animal intestinal tract (25). These
findings have defined the importance of CmeABC in the an-
timicrobial resistance and pathophysiology of Campylobacter.
Even though basal production of CmeABC in wild-type
strains occurs at a level that can readily be detected with
antibodies specific to the efflux pumps (24), little is known
about the regulatory mechanisms that modulate the expression
of cmeABC in Campylobacter cells. Understanding the regula-
tory system for CmeABC will provide new insights into the
mechanisms by which Campylobacter contributes to multidrug
resistance (MDR) and adaptation to environmental changes.
In this study, we report on the identification of CmeR as a
transcriptional repressor for CmeABC. The cmeR gene is
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located immediately upstream of cmeA and encodes a 210-
amino-acid (aa) protein that shares sequence and structure
similarities to the members of the TetR family of tran-
scriptional repressors. Using various approaches, we show that
CmeR represses the transcription of cmeABC by directly bind-
ing to the promoter region (specifically, to the inverted repeat
[IR]) of the efflux operon. Mutations in CmeR or the CmeR-
binding site impede the repression and result in the overex-
pression of CmeABC and enhanced resistance to multiple
antibiotics.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The various Campylo-
bacter strains, mutants, and plasmids used in this study and their sources are
listed in Table 1. These isolates were routinely grown in Mueller-Hinton (MH)
broth (Difco) or agar at 42°C under microaerobic conditions, which were gen-
erated with a Campypak Plus (Becton Dickinson) gas pack in an enclosed jar.
When needed, MH media were supplemented with kanamycin (30 g/ml) or
chloramphenicol (4 g/ml). E. coli cells were grown at 37°C with shaking at 200
rpm in Luria-Bertani (LB) medium. When needed, LB media were supple-
mented with kanamycin (30 g/ml) or ampicillin (100 g/ml).
PCR. All primers used for PCR are listed in Table 2. PCR was performed in
a volume of 100 l containing 200 M each deoxynucleoside triphosphate, 200
nM primers, 2.5 mM MgSO4, 50 ng of Campylobacter genomic DNA, and 5 U of
Taq DNA polymerase (Promega) or Pfu Turbo DNA polymerase (Stratagene).
Cycling conditions varied according to the estimated annealing temperatures of
the primers and the expected sizes of the products. To amplify the 0.9-kb coding
sequence of cmeR from C. jejuni 81-176, primers F and R were designed from the
genomic sequence of C. jejuni NCTC 11168 (35) and were used in the PCR along
with the genomic DNA of strain 81-176 and Taq DNA polymerase. PCR prod-
ucts were purified with a QIAquick PCR purification kit (Qiagen) and subse-
quently sequenced. To insert the cat gene cassette into the cmeR gene, primers
CHLF and CHLR (Table 2) were used in the PCR with Pfu Turbo7 DNA
polymerase to amplify the entire cat gene from shuttle vector pUOA18 (49). To
determine the binding of CmeR to the cmeABC promoter, primers GSF and
GSR1 were used to amplify the 170-bp DNA fragment that contains the inter-
genic region (IT) from wild-type strain 81-176 and its mutant, strain CR3e, for
gel mobility shift assays. Reverse primers GSR2, GSR3, and GSR4 were used in
conjunction with primer GSF to map the specific CmeR-binding site in the IT.
The locations of these PCR primers are indicated in Fig. 1A.
Sequence analysis and prediction of secondary structures. PCR products were
sequenced with an automated DNA sequencer (model 377; Applied Biosystems).
Sequence analysis was performed with the Genetics Computer Group (GCG)
Sequence Analysis Software Package (Oxford Molecular). The BLAST program
(http://www.ncbi.nlm.nih.gov/BLAST/) of the National Center for Biotechnology
Information was used to search for homologous sequences and conserved do-
mains in CmeR. The MOTIF program (http://motif.genome.jp) was also used to
search for protein motifs in CmeR. The Peptidestructure program in GCG was
used to make an initial prediction of the secondary structures of CmeR. Other
TABLE 1. Bacterial plasmids and strains used in this study
Plasmid or strain Description Source or reference
Plasmids
pGEMT-Easy PCR cloning vector, Ampr Promega
pCMER pGEMT-Easy containing full-length cmeR fragment, Ampr This study
pCMERC pCMER with chloramphenicol resistance cassette inserted in cmeR, Ampr Cmr This study
pMW10 E. coli-C. jejuni shuttle vector with promoterless E. coli lacZ gene, Kanr 52
pIT81 pMW10 derivative with the cmeABC promoter of wild-type C. jejuni 81-176 inserted upstream of lacZ This study
pIT3e pMW10 derivative with the cmeA promoter of C. jejuni CR3e inserted upstream of lacZ This study
pRK2013 IncP Tra RK2 repRK2 repE1, Kanr 6
pQE-30 Expression vector, Ampr Qiagen
pQE-CmeR pQE-30 derivative expressing full-length recombinant CmeR protein This study
Strains
C. jejuni
NCTC 11168 Wild type; genome sequence known 35
81-176 Wild type; isolated from a human 4
CR3e 81-176 derivative; spontaneous fluoroquinolone-resistant mutant obtained after stepwise selection
with ciprofloxacin
This study
9B6 81-176 derivative; cmeB::kan 24
JL106 81-176 derivative; cmeC::kan 25
JL107 81-176 derivative; cmeR::cm This study
JL108 81-176 containing pMW10 This study
JL109 JL107 containing pMW10 This study
JL110 81-176 containing pIT81 This study
JL111 JL107 containing pIT81 This study
JL112 81-176 containing pIT3e This study
E. coli
JM109 endA1 recA1 gyrA96 thi hsdR17 (rk
, mk
) relA1 supE44 (lac-proAB) [F traD36 proAB lacIqZM15] Promega
DH5 F 80lacZM15 (lacZYA-argF)U169 recA1 endA1 hsdR17 (rk
, mk
) phoA supE44 thi-1 gyrA96 relA1  Invitrogen
TABLE 2. Oligonucleotide primers used in this study
Primer Sequencea
F ..........................5-TAGAAAAGTATATTTGTATACCCT-3
R .........................5-CGCCACTAACTTGAGGCTTTA-3
R1 .......................5-AATTTTTGGCTAATTATATCTTAATTT-3
CHLF .................5-TGCTCGGCGGTGTTCCTTT-3
CHLR.................5-GCGCCCTTTAGTTCCTAAAG-3
RF .......................5-ATAGGATCCATGAACTCAAATAGAACACCA-3
(BamHI)
RR ......................5-TTTTAAGCTTTGGAGCTATTGATT-3 (HindIII)
GSF.....................5-CTAAATGGAATCAATAGCTCC-3
GSR1 ..................5-GCACAACACCTAAAGCTAAAA-3
GSR2 ..................5-TAAAAATTGTAATATTTATTACAG-3
GSR3 ..................5-ATTGTAATATTTATTACAGAAATT-3
GSR4 ..................5-GAAATTTTTGGCTAATTATAT-3
AF .......................5-AACCTCAAGTTAGCGGCGTA-3
AR ......................5-AATCCTTGCTTGCATTTTCG-3
PF........................5-AAAAGGATCCTAAATGGAATCAATAGCTCC-3
(BamHI)
PR .......................5-ATCTCGGTATGATCTAGATCA-3 (XbaI)
a Underlining indicates restriction sites. The names of the restriction sites are
listed in parentheses following the sequences.
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programs, including SOMP and SOSUI (BCM Search Launcher Texas, Baylor
College of Medicine [http://searchlauncher.bcm.tmc.edu/seq-search/struc-predict.html]),
were also used to improve the prediction power.
Insertional mutation of cmeR. An isogenic cmeR mutant was first constructed
by insertional mutagenesis in strain NCTC 11168. The cmeR mutation was then
introduced into strain 81-176 by natural transformation. To construct the cmeR
mutant in NCTC 11168, primers F and R1, designed from the published genomic
sequence (35), were used to amplify a 729-bp fragment containing the entire
open reading frame (ORF) of cmeR. The PCR product was cloned into the
pGEMT-Easy vector (Promega), resulting in the construction of pCMER. Since
a unique BsrBRI site (which generates blunt ends) occurs in the middle of cmeR,
pCMER was digested with BsrBRI to interrupt the cmeR gene. Primers CHLF
and CHLR were used to amplify the 802-bp cat gene cassette from pUOA18 (49)
by using Pfu Turbo DNA polymerase (Stratagene). The cat PCR product was
directly ligated to BsrBRI-digested pCMER to obtain construct pCMERC. Se-
quencing of the construct indicated that the cat gene was inserted within the
codon encoding aa 127 of CmeR in the same direction as the transcription of
cmeR. The pCMERC construct, which served as a suicide vector, was electro-
porated into C. jejuni NCTC 11168. Transformants were selected on MH agar
containing 4 g of chloramphenicol per ml. Inactivation of the cmeR gene in the
transformants by insertion of the cat gene was confirmed by PCR. To create the
isogenic cmeR mutant in strain 81-176, the insertional mutation in cmeR of
NCTC 11168 was transferred into strain 81-176 by natural transformation. The
cmeR mutation in 81-176 was further confirmed by PCR. The cmeR mutant of
81-176 was named JL107. The levels of the CmeABC products in the cmeR
mutant were determined by immunoblotting with anti-CmeB and anti-CmeC
antibodies, as described previously (24). The density of each band was analyzed
with the ChemilmagerIS-5500 digital imaging system (Alpha Innotech).
In vitro selection of fluoroquinolone-resistant mutants. Fluoroquinolone-
susceptible wild-type strain 81-176 was used as the parental strain for plating.
Spontaneous fluoroquinolone-resistant mutants were obtained by stepwise se-
lection on MH agar plates containing ciprofloxacin (ICN Biomedicals Inc.). At
the first step, 200 l of 2-day cultures of 81-176 containing approximately 2	 109
CFU were plated on MH agar plates supplemented with 4 g of ciprofloxacin per
ml. Resistant colonies were selected, one of which was used for further plating
with an increased ciprofloxacin concentration. The selection and plating process
was repeated three times, and the final concentration of ciprofloxacin used for
plating was 80 g/ml. One clone (clone CR3e) from the final selection step was
chosen for use in this study.
Susceptibility tests. The MICs of different antimicrobials for Campylobacter
were determined by a microtiter broth dilution method as described in a previous
publication (24). Briefly, Campylobacter cultures were grown in MH broth to the
late log phase and then diluted in MH broth to obtain an inoculum with approx-
imately 2 	 107 CFU of bacterial cells per ml. Antimicrobial stock solutions were
serially diluted twofold in 96-well microtiter plates with MH broth. The starting
concentrations for the twofold dilution series were 100 mg/ml for cholic acid and
choleate; 5 mg/ml for sodium dodecyl sulfate (SDS) and fusidic acid; 100 g/ml
for ciprofloxacin, norfloxacin, tetracycline, and cefotaxime; and 5 g/ml for
ampicillin, ethidium bromide, and erythromycin. The volume in each well was
120 l. Two wells were used for each dilution of the antimicrobials. To each well,
5 l of the bacterial inoculum was added, resulting in a final bacterial density of
8 	 105 CFU/ml. The microtiter plates were incubated for 2 days under mi-
FIG. 1. Control of cmeABC transcription by CmeR in strain 81-176. (A) Genomic organization and features of the intergenic region between
cmeR-cmeABC. ORFs are indicated by boxed arrows. The start codon (ATG) of cmeA is in bold italics, and the sequences that form the IR
(5-TGTAATA-3) are highlighted in bold and indicated by dashed arrows. The putative ribosome-binding site (AAGGCA) is underlined. The
predicted 10, 16, and 35 regions of PcmeABC are overlined. The single nucleotide that was found to be deleted in CR3e is indicated by an
asterisk. The locations of the key primers used for PCR are indicated by arrows. The location and orientation of the cat gene cassette (labeled Cmr)
insertion in cmeR are indicated by a solid arrow. (B) Sequence alignment of the N-terminal DNA-binding domains of five repressors belonging
to the TetR family. The numbers following the name of each protein indicate the amino acid numbers in each corresponding protein. The regions
forming  helices are indicated by the boxes above the alignment. The HTH motif is also labeled. (C) Immunoblotting analysis of the CmeB protein
in wild-type strain 81-176 and its mutants. Cell envelopes prepared from strains 81-176 (lane 2), 9B6 (lane 3; CmeB), JL107 (lane 4; CmeR),
and CR3e (lane 5) were separated by SDS-PAGE and immunoblotted with anti-CmeB. The same amounts of total proteins were loaded in each
lane. Prestained molecular mass markers (Bio-Rad) are shown in lane 1.
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croaerophilic conditions at 42°C. Three independent experiments were con-
ducted to confirm the reproducibilities of the MIC patterns. The compounds used
in these assays were purchased from Sigma Chemical Co. (norfloxacin, tetracy-
cline, ampicillin, cefotaxime, erythromycin, fusidic acid, cholic acid, and choleate),
ICN Biomedicals Inc. (ciprofloxacin), EM Science (SDS), and AMRESCO (ethid-
ium bromide).
Production and purification of rCmeR. A full-length histidine-tagged recom-
binant CmeR (rCmeR) was produced in E. coli by using the pQE-30 vector of the
QIAexpress7 Expression System (Qiagen). The complete coding sequence of
cmeR in C. jejuni 81-176 was amplified with primers RF and RR (Table 2). A
restriction site (underlined in the primer sequences in Table 2) was attached to
the 5 end of each primer to facilitate the directional cloning of the amplified
PCR product into the pQE-30 vector. The amplified PCR product was digested
with BamHI and HindIII and was then ligated into the pQE-30 vector, which had
previously been digested with BamHI and HindIII. Cloning, expression, and
purification of recombinant CmeR were performed by the procedures described
previously (24, 54). The plasmid in the E. coli clone producing CmeR was se-
quenced, with no mutations in the coding sequence of cmeR detected.
Electrophoretic mobility shift assays. To determine the binding of CmeR to
the operator region of cmeABC, electrophoretic mobility shift assays were per-
formed by the procedure described by Alekshun et al. (2), with slight modifica-
tions. Primers GSF and GSR1 (Table 2) were used to amplify the 170-bp
cmeR-cmeA IT, which was then labeled at the 3 end with digoxigenin-11-ddUTP
(DIG-11-ddUTP) by using the DIG Oligonucleotide 3-End Labeling kit (Roche
Molecular Biochemicals). An internal cmeA fragment amplified with primers AF
and AR (Table 2) was labeled with DIG-11-ddUTP and was used as the control
DNA for the gel shift assay. The DIG-11-ddUTP-labeled DNA fragments (0.2
pmol) were incubated with purified rCmeR in amounts ranging from 9.4 ng to 1.2
g in 20 l of binding buffer containing 20 mM HEPES (pH 7.6), 1 mM EDTA,
10 mM (NH4)2SO4, 5 mM dithiothreitol, 0.2% Tween 20, 30 mM KCl, and 25 ng
of poly(dI-dC). The reaction mixtures were incubated at room temperature for
15 min and were then subjected to electrophoresis on a nondenaturing 6%
(wt/vol) polyacrylamide gel in 0.25	 TBE (22 mM Tris, 22 mM boric acid, 0.5
mM EDTA [pH 8.0]) at 200 V for 45 min. The DNA in the gels was transferred
to a nylon membrane with a vacuum blotter. DIG-labeled DNA was detected and
visualized by using alkaline phosphatase-conjugated anti-DIG antibody and the
chemiluminescent substrate CDP-Star (Roche Molecular Biochemicals). For the
competition experiments, different amounts (50-, 150-, and 300-fold molar ex-
cesses) of unlabeled DNA were added as competitors during the binding assays.
To identify the specific CmeR-binding site, reverse primers GSR2, GSRR3, and
GSR4 (Table 2; Fig. 1A) were used with primer GSF to generate DNA fragments
spanning different portions of the IT between cmeR and cmeA. The PCR frag-
ments were labeled with DIG and used for the DNA-binding assays, as described
above.
Construction of promoter fusions. A 640-bp DNA fragment containing
PcmeABC and its flanking region was amplified from wild-type strain 81-176 with
primer pair PF and PR (Table 2; Fig. 1A). The amplified PCR products were
digested with BamHI and XbaI and then inserted into plasmid pMW10, a shuttle
vector carrying a promoterless lacZ gene (52), to create plasmid pIT81. The same
promoter region in mutant CR3e was also amplified by PCR and inserted into
pMW10 to create plasmid pIT3e. Plasmids pIT81, pIT3e, and pMW10 were
mobilized into various C. jejuni strains by triparental mating by using DH5/
pRK2013 (6) as the helper strain, according to the procedure described by Miller
et al. (31).
-Galactosidase assay. The 
-galactosidase (LacZ) activity in the Campy-
lobacter strains containing the PcmeABC-lacZ transcriptional fusion was measured
as described by Miller (30), with the modification that C. jejuni cultures were
grown for 16 h in MH broth to log phase (absorbance at 600 nm, approximately
0.2) before they were harvested. All assays were conducted in triplicate.
Nucleotide sequence accession number. The cmeR gene sequence of C. jejuni
81-176 determined in this study was deposited in GenBank under accession
number AF466820.
RESULTS
Sequence features of cmeR and IT between cmeR and
cmeABC in C. jejuni 81-176. Analysis of the genomic sequence
of C. jejuni NCTC 11168 (35) suggested that Cj0368c, an ORF
immediately upstream of the cmeABC operon, likely encodes a
transcription factor. The homolog of Cj0368c in strain 81-176
was amplified by PCR with primers F and R (Fig. 1A; Table 2)
and subsequently sequenced and was named cmeR in this
study. cmeR encodes a 210-aa protein and is transcribed in the
same direction as cmeABC (Fig. 1A). The deduced amino acid
sequence of CmeR in 81-176 is 99.5% identical to the encoded
product of Cj0368c in strain NCTC 11168. CmeR shares se-
quence similarities with the members of TetR family of tran-
scriptional repressors of efflux systems (Pfam accession num-
ber PF00440). In particular, the N-terminal region of CmeR
contains a DNA-binding domain that is highly conserved
among the TetR family regulators (Fig. 1B), including QacR
(GenBank accession number AF053772; 50% identity in 52 aa
of overlap) of S. aureus, AcrR (GenBank accession number
U00734; 40% identity in 60 aa of overlap) of E. coli, and MtrR
(GenBank accession number Z25797; 31% identity in 83 aa of
overlap) of Neisseria gonorrhoeae. Within the domain, an -he-
lix–turn–-helix (HTH) DNA-binding motif, a signature se-
quence of the TetR family regulators, is also present in CmeR
(aa 30 to 60) (Fig. 1B). There is a 97-bp IT between cmeR and
cmeA, in which an IR consisting of 7-bp half sites separated by
a 2-bp spacer was identified (Fig. 1A). On the basis of the
reported consensus promoter sequence of Campylobacter (52),
the putative 10, 16, and 35 sequences were identified for
the promoter of cmeABC in C. jejuni 81-176 (Fig. 1A). The IR
is located between the predicted 10 and 35 sequences, and
the 35 region partly overlaps with the half site of the IR.
These sequence features suggested that CmeABC is subject to
regulation and CmeR is likely a local regulator for CmeABC.
Insertional mutagenesis of cmeR increases the level of
cmeABC expression. To determine if CmeR functions as a
regulator for CmeABC, CmeR was inactivated by inserting the
chloramphenicol resistance gene (cat) cassette into the codon
encoding aa 127 of CmeR (Fig. 1A). As shown by immuno-
blotting (Fig. 1C, lane 4), the level of production of CmeB in
the cmeR mutant (named JL107) of strain 81-176 was substan-
tially higher than that in the wild type. Spot densitometric
analysis of the immunoblot estimated that JL107 produced
approximately fivefold more CmeB than wild-type 81-176. To
determine if the increased level of production of CmeB in
JL107 was due to an elevated level of transcription of cmeABC,
the promoter sequence (PcmeABC) of cmeABC in 81-176 was
placed upstream of the promoterless lacZ gene in plasmid
pMW10 to create transcriptional fusion plasmid pIT81 (Table
1), which was then transformed into wild-type strain 81-176
and JL107. As shown in Table 3, the LacZ activity in JL108 and
JL109 (which carried the control plasmid pMW10) was barely
detectable, indicating that the endogenous level of expression
of the promoterless lacZ was low and negligible. On the basis
of the measurement of 
-galactosidase activity, PcmeABC was
moderately active (236 Miller units) in wild-type strain 81-176
TABLE 3. Effects of mutations in cmeR or the IT on
cmeABC transcription
Strain Description 
-Galactosidase activity(Miller units)a
JL108 81-176 with pMW10 1.45  0.25
JL109 JL107 (cmeR::cm) with pMW10 2.08  0.30
JL110 81-176 with pIT81 236  2
JL111 JL107 (cmeR::cm) with pIT81 1,467  21
JL112 81-176 with pIT3e 586  20
a Means of triplicate measurements  standard deviation.
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(shown for strain JL110 in Table 3), which was consistent with
the fact that the CmeABC proteins were detectable by immu-
noblotting in the wild-type strain (Fig. 1C) (24). However, in
the absence of a functional CmeR, the level of transcription of
PcmeABC was elevated approximately 6.2-fold (to 1,467 Miller
units; shown in strain JL111) over the wild-type level. The fold
difference in the level of transcription of PcmeABC between
wild-type strain 81-176 and the cmeR mutant was comparable
to that from the immunoblotting results, shown in Fig. 1C.
Inactivation of CmeR in strain NCTC 11168 also resulted in
cmeABC overexpression (data not shown), further confirming
the role of CmeR in controlling cmeABC. Together, these re-
sults indicate that CmeR represses the transcription of cmeABC
and that inactivation of CmeR results in the overexpression of
the efflux operon.
CmeR binds to the IT between cmeR and cmeA. To deter-
mine if CmeR regulates the cmeABC operon via direct inter-
action with the promoter of cmeABC, a gel mobility shift assay
was performed with rCmeR and the IT DNA amplified with
primers GSF and GSR1 (Fig. 1A; Table 2). rCmeR showed a
molecular mass of approximately 23 kDa on SDS-polyacryl-
amide gel electrophoresis (PAGE) (Fig. 2A), consistent with
the calculated molecular mass from the deduced amino acid
sequence of CmeR. As shown in Fig. 2B, rCmeR bound to the
IT DNA but not to the control DNA, which was a 170-bp
internal fragment of cmeA amplified by PCR with primers AF
and AR (Table 2). The specific interaction between rCmeR
and the IT DNA was further confirmed by a competition assay
(Fig. 2C). The addition of a 50-fold molar excess of the unla-
beled IT DNA (Fig. 2C, lane 3) completely eliminated the
formation of the DNA-protein (D-P) complex, while the
170-bp control DNA did not have any effect on rCmeR binding
to the IT, even at a molar excess as high as 300-fold (Fig. 2C,
lanes 6 to 8). Together, these findings indicate that CmeR
specifically binds to the promoter region of cmeABC. When
different concentrations of rCmeR were used in the DNA-
binding assay, a single retarded D-P complex was always ob-
served on the gel (data not shown), suggesting that there is
only one CmeR-binding site in the IT region.
The IR in the IT is required for specific CmeR binding.
Regulators of bacterial MDR efflux systems usually bind to the
IRs in their target promoter regions (14). The presence of an
IR upstream of cmeABC (Fig. 1A) suggested a potential bind-
ing site for CmeR. To examine this possibility, the gel mobility
shift assay was performed with a series of PCR products whose
sequences span different portions of the IT region between
cmeR and cmeABC (see Fig. 1A for the locations of the prim-
ers). As shown in Fig. 3A, rCmeR bound to the DNA frag-
ments amplified by primers GSF and GSR1 or primers GSF
and GSR2, and partial binding was also observed with the
fragment amplified with primers GSF and GSR3. However,
the PCR fragment lacking the IR derived with primers GSF
and GSR4 was not bound by rCmeR, because no retarded
rCmeR-DNA complex was observed on the gel (Fig. 3A, lane
8). These observations strongly indicate that the IR is the
binding site for CmeR. The reduced level of binding of CmeR
to the fragment obtained by PCR with primers GSF and GSR3
suggested that the immediate flanking sequence of the IR is
also required for full binding by CmeR.
Mutation in the IR affects expression of cmeABC. A spon-
taneous MDR mutant (designated CR3e) of strain 81-176,
obtained by stepwise selection on ciprofloxacin-containing
plates, showed high levels of resistance to fluoroquinolones
and concurrently elevated levels of resistance to several other
antibiotics (Table 4), although ciprofloxacin was the exclusive
antimicrobial used in the stepwise selection. Immunoblotting
analysis of the CmeABC proteins in CR3e indicated that the
efflux proteins are overexpressed in this mutant (Fig. 1C, lane
5). To determine the mechanism responsible for the increased
level of production of CmeABC in CR3e, the complete cmeR
gene and the IT region between cmeR and cmeA were ampli-
FIG. 2. Binding of rCmeR to the IT region between cmeR-
cmeABC. (A) SDS-PAGE analysis of rCmeR produced in E. coli. Lane
1, prestained molecular mass markers (Bio-Rad); lane 2, whole-cell
lysate of noninduced E. coli; lane 3, whole-cell lysate of E. coli induced
with 1 mM isopropyl-
-D-thiogalactopyranoside; lane 4, rCmeR puri-
fied by Ni-nitrilotriacetic acid affinity chromatography. (B) Gel mobil-
ity shift assays with the IT DNA (lanes 1 to 3) or the control DNA (an
internal cmeA fragment; lanes 4 to 6). In the DNA-binding assay, the
DIG-11-dUTP-labeled DNA (0.2 pmol) was incubated with 0 ng (lanes
1 and 4), 75 ng (lanes 2 and 5), and 37.5 ng (lanes 3 and 6) of rCmeR.
(C) Competition assay to determine the binding specificity of CmeR.
In the DNA-binding reactions, the DIG-11-dUTP-labeled IT DNA
was incubated with 0 ng (lane 1) or 37.5 ng (lanes 2 to 8) of rCmeR in
the presence of the unlabeled IT DNA (lanes 3 to 5) or the control
DNA (lanes 6 to 8). The unlabeled DNA was added at a 50-fold (lanes
3 and 6), 150-fold (lanes 4 and 7), or 300-fold (lanes 5 and 8) molar
excess of the labeled IT DNA. The positions of the DIG-labeled IT
(D) and the IT-rCmeR complex (D/P) are indicated in panels B and C.
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fied from CR3e by PCR. Sequence analysis indicated that the
cmeR gene in mutant CR3e is identical to the one in wild-type
strain 81-176, indicating that mutation in CmeR was unlikely
the reason for the enhanced production of CmeABC in CR3e.
However, a single nucleotide deletion (marked by an asterisk
in Fig. 1A) occurred between the two half sites of the IR in the
promoter region of cmeABC, which was the only mutation
found in the entire IT. Since the IR was the binding site for
CmeR, we hypothesized that the single nucleotide deletion
affected the binding by CmeR, resulting in overexpression of
CmeABC in mutant CR3e. To test this hypothesis, a gel mo-
bility shift assay was performed with the IT DNA derived from
strains 81-176 and CR3e and different amounts of rCmeR. As
shown in Fig. 3B, as little as 4.8 ng of rCmeR could form a
detectable D-P complex with 81-176-derived IT DNA (Fig. 3B,
lane 4). However, at least twice the amount of rCmeR (9.5 ng)
was needed to form a visible D-P complex when the IT DNA
derived from CR3e was used in the assay (Fig. 3B, lane 8). This
finding was reproducible in three independent experiments
and indicates that the binding of CmeR to the promoter region
of cmeABC in CR3e is reduced due to the single nucleotide
deletion between the half sites of the IR. To further examine
the impact of the single nucleotide deletion on the transcrip-
tion of cmeABC, the PcmeABC sequence bearing the single de-
letional mutation was transcriptionally fused to the promoter-
less lacZ in pMW10 to create pIT3e, which was then
introduced into wild-type strain 81-176 to create strain JL112
(Table 1). As shown in Table 3, the 
-galactosidase activity was
approximately 2.5-fold higher in JL112 (which contained the
mutated promoter-lacZ fusion) than in JL110 (which con-
tained the wild-type promoter-lacZ fusion), indicating that the
mutated PcmeABC is more active than the wild-type PcmeABC
and that the single deletional mutation increases the level of
transcription of cmeABC in CR3e.
Overexpression of cmeABC correlates with enhanced resis-
tance to multiple antibiotics. Compared to wild-type strain
81-176, the CmeR mutant (strain JL107) showed enhanced
resistance to several antibiotics (Table 4). The MICs of cipro-
floxacin, norfloxacin, cefotaxime, and fusidic acid for JL107
increased twofold and the MIC of erythromycin for JL107
increased fourfold. The MIC results and the moderate differ-
ences in the MICs for the cmeR mutant and those for wild-type
strain 81-176 were reproducible in three independent experi-
ments. Seven consecutive passages (168 generations) of
JL107 in MH broth showed the same MIC changes, indicating
that the phenotype is stable. Although tetracycline, ampicillin,
ethidium bromide, cholic acid, choleate, and SDS are sub-
strates of CmeABC (24), mutant JL107 showed only a wild-
type level of resistance to these substances. Overexpression of
cmeABC in spontaneous mutant CR3e also appeared to be
correlated with the MDR phenotype of the mutant. Although
the Thr-86-Ile point mutation was present in the gyrA gene of
CR3e (data not shown), the exceedingly high level of resistance
to ciprofloxacin (Table 4) may be explained by the overexpres-
sion of cmeABC. In addition, the enhanced resistance of CR3e
to tetracycline, ampicillin, cefotaxime, erythromycin, and fu-
sidic acid was at least partially attributable to the overex-
pressed cmeABC.
DISCUSSION
This work demonstrates that CmeR functions as a transcrip-
tional repressor for CmeABC and that the interaction of
CmeR with the IR immediately upstream of cmeABC regulates
the expression of this MDR operon. This conclusion is based
TABLE 4. Susceptibilities of C. jejuni 81-176, JL107, and
CR3e to different antimicrobials
Antimicrobial
MIC (g/ml)a
81-176 JL107 CR3e
Ciprofloxacin 0.390 0.780 (2) 100 (256)
Norfloxacin 0.098 0.196 (2) 6.25 (64)
Tetracycline 0.098 0.098 () 0.196 (2)
Ampicillin 0.625 0.625 () 2.5 (4)
Cefotaxime 0.390 0.780 (2) 1.56 (4)
Erythromycin 0.039 0.156 (4) 0.156 (4)
Ethidium bromide 0.625 0.625 () 0.625 ()
Fusidic acid 39 78 (2) 78 (2)
Cholic acid 3,125 3,125 () 3,125 ()
Choleate 12,500 12,500 () 25,000 (2)
SDS 156 156 () 156 ()
a The numbers in parentheses indicate the fold differences in MICs between
81-176 and its mutant derivatives. , no MIC difference was observed.
FIG. 3. Localization of the specific binding site of CmeR. (A) Gel
mobility shift assay with IT DNA amplified with primers GSF and
GSR1 (lanes 1 and 2), GSF and GSR2 (lanes 3 and 4), GSF and GSR3
(lanes 5 and 6), or GSF and GSR4 (lanes 7 and 8). The PCR products
were end labeled with DIG-11-dUTP and incubated with 0 ng (lanes 1,
3, 5, and 7) or 75 ng (lanes 2, 4, 6, and 8) of rCmeR. The positions of
the retarded IT-rCmeR complex are indicated by arrows. (B) Effect of
a single nucleotide deletion in the spacer of the IR on the binding of
CmeR. In the gel mobility shift assay, The DIG-labeled IT DNA from
wild-type strain 81-176 (lanes 1 to 5) or clone CR3e (lanes 6 to 10) was
incubated with 0 ng (lanes 1 and 6), 19 ng (lanes 2 and 7), 9.5 ng (lanes
3 and 8), 4.8 ng (lanes 4 and 9), or 2.4 ng (lanes 5 and 10) of CmeR.
The positions of the DIG-labeled IT (D) and the IT-rCmeR complex
(D/P) are indicated on the right.
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on the following evidence. First, CmeR shares significant se-
quence and structural homologies with known repressors
belonging to the TetR family of transcriptional regulators.
Second, inactivation of CmeR by insertional mutagenesis sub-
stantially increased the level of transcription of cmeABC and,
consequently, enhanced the level of production of the Cme-
ABC proteins (Table 3 and Fig. 1C). Third, CmeR specifically
bound to the unique IR upstream of cmeA, as shown by the gel
mobility shift assay (Fig. 2 and Fig. 3A). Finally, a mutation in
the IR (a 1-bp deletion between the two half sites) significantly
reduced the level of binding by CmeR (Fig. 3B) and resulted in
enhanced transcription (Table 3) and translation (Fig. 1C) of
the efflux operon. Together, these findings formally define the
critical role of CmeR and its specific binding site on the reg-
ulation of CmeABC in C. jejuni.
CmeR represses the transcription of cmeABC, but it also
allows a moderate level of production of the efflux proteins in
wild-type strains in the absence of antibiotics. This feature is
different from the control of TetA by TetR, in which the basal
level of expression of tetA is minimal in the absence of tetra-
cycline (14). The difference is probably due to the fact that the
TetA pump is specific for tetracycline and constitutive expres-
sion of tetA is not required in the absence of the substrate (19).
In contrast, the other efflux pumps that are controlled by re-
pressors of the TetR family and that have a broad spectrum of
substrates (e.g., AcrAB, MtrCDE, and QacA) are expressed at
substantial levels in wild-type strains even in the absence of
specific substrates (12, 15, 48). This relatively high basal level
of expression of the MDR pumps is probably required for their
key roles in conferring intrinsic resistance to different antimi-
crobials and toxic compounds and facilitates the adaptation
of bacterial organisms to environmental changes. In addition,
bacterial MDR pumps are likely required for extrusion of
endogenous toxic metabolites (18, 37), which also necessitates
constitutive expression of the efflux pumps even in the absence
of exogenous selection pressure. On the other hand, the over-
production of efflux pumps in the absence of selection pressure
or substrates has been demonstrated to be deleterious to some
organisms (7, 32, 43). Therefore, there is a need for regulatory
systems to modulate the expression of MDR efflux pumps in
bacteria. In this respect, CmeR acts as a moderator in Campy-
lobacter to maintain balanced production of CmeABC to meet
the physiological needs and facilitate the adaptation of Campy-
lobacter to environmental changes, including antibiotic treat-
ments.
The cmeR gene was inactivated by the insertion of an anti-
biotic resistance gene cassette in the middle of the ORF (Fig.
1). Although there was a possibility that the truncated N-
terminal portion of CmeR was still produced in the mutant
strain, it is unlikely that the truncated version of CmeR was
functional in repressing the transcription of cmeABC. CmeR
belongs to the TetR family, and the members of this family
function as dimers. Although the DNA-binding motif is lo-
cated in the N-terminal portion, the C-terminal portion is
essential for dimer formation (14). Deletion of the C-terminal
portion of the regulatory protein in the TetR family would
prevent the formation of dimers and, consequently, would af-
fect the binding to target DNA. Hence, the truncated CmeR,
even if it were produced in the mutant strain, is not expected
to perform the repressor function, as is the case with the
full-length CmeR. This argument is directly supported by the
findings that the CmeR mutant showed a significant increase in
the level of transcription of cmeABC and the level of produc-
tion of the efflux proteins (Table 3 and Fig. 1). Regardless of
the expression status of the truncated CmeR in the mutant, the
results from this study demonstrate that CmeR functions as a
repressor for CmeABC. To determine if CmeR directly bound
to the promoter sequence of cmeABC, His-tagged rCmeR was
produced in E. coli and was used for the gel mobility shift
assay. His-tagged recombinant proteins have commonly been
used to assess the binding of MDR pump repressors to target
DNA (9, 12, 42). It was unlikely that the His tag attached to
rCmeR had any effect on DNA binding because rCmeR did
not bind to the negative control DNA (internal cmeA frag-
ment), while it bound specifically to the promoter DNA of
cmeABC (Fig. 2). In addition, the binding specificity was fur-
ther verified by competition with the nonlabeled promoter
DNA and mutation of the binding site (Fig. 2 and 3).
The IR is a typical DNA motif for binding sites of regulatory
proteins (14). It has been known that the correct spacing be-
tween the two half sites of an IR is critical for binding by
repressors (13, 51). For example, Wissmann et al. (51) showed
that a 1-bp increase or decrease in the single-base-pair spacing
between the two half sites of the tet operator decreased the
affinity of the operator sequence to TetR. Another study with
staphylococcal QacR (13) also demonstrated that binding of
QacR was dependent on correctly spaced operator half sites.
In this study, we found that CmeR bound specifically to the IR
in the promoter region of CmeABC (Fig. 3) and that a single
nucleotide deletion between the two half sites of the IR re-
duced the level of CmeR binding to the promoter sequence of
cmeABC (Fig. 3B) and led to a 2.5-fold increase in the level
of transcription of PcmeABC (Table 3). On the basis of these
findings, we can confidently link the enhanced expression of
cmeABC in mutant CR3e to the single nucleotide deletion in
the IR. The sequence feature of the IR upstream of cmeABC
is similar to that of the IR bound by TetR, which comprises
9-bp half sites separated by a 1-bp spacer (14, 51), but is
different from that of the large QacR-binding region compris-
ing 15-bp half sites separated by a 6-bp spacer (12). On the
basis of the sequence analogy of the binding sites and the
known binding mechanisms of TetR and QacR (13, 20), it is
speculated that CmeR may bind to its operator as a dimer in a
way similar to that of TetR rather than to a pair of dimers, as
is the case with QacR (13). This speculation remains to be
examined in future studies.
Overexpression of MDR efflux pumps mediated by muta-
tions in their regulatory elements is usually associated with
acquired resistance to multiple antibiotics in bacteria (36, 37,
50). The results from this study also indicate that overexpres-
sion of CmeABC increases the levels of resistance of Campy-
lobacter to several antimicrobials (Table 4). On the basis of the
MIC, the enhanced resistance in the isogenic CmeR mutant
(strain JL107) was moderate, but the differences were repro-
ducible in independent experiments. At this stage it is unclear
why the overexpression of CmeABC mediated by the CmeR
mutation did not cause large changes in the MICs for the
CmeR mutant. There is a possibility that CmeR also regulates
other unidentified genes and that inactivation of CmeR may
have pleiotropic effects on gene expression in Campylobacter,
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which potentially obscures the changes in MICs. This possibil-
ity is being examined in our laboratory. Nevertheless, the rel-
atively small-scale increase in the resistance profiles of the
CmeR mutant is not totally surprising, because it has been
found in other bacteria that overexpression of a single MDR
pump caused by mutations in its local repressor may not confer
drug resistance to a level of clinical significance (21, 38, 47).
However, overexpression of MDR pumps may allow bacteria
to survive under the pressure of high antibiotic concentrations
and promote the emergence of mutants with specific target
gene mutations that are highly resistant to antimicrobials (46,
50). The contribution of CmeABC overexpression to the ac-
quired antibiotic resistance in Campylobacter remains to be
determined in future studies.
In mutant CR3e, which was obtained by stepwise selection
on ciprofloxacin-containing plates, the high-level resistance to
fluoroquinolones (Table 4) was expected because the mutant
contained the specific GyrA mutation (Thr-86-Ile), which, in
conjunction with the function of CmeABC, confers a high level
of resistance to fluoroquinolones (26). The enhanced resis-
tance of CR3e to other antimicrobials (Table 4) is at least
partially attributable to the overexpression of CmeABC in the
mutant. However, there is a possibility that other unknown
mutations might also have occurred, and these might also have
contributed to the increased level of antibiotic resistance in
CR3e. Due to technical difficulties, our effort to introduce the
single nucleotide deletion in the cmeABC promoter of CR3e
into wild-type 81-176 by using natural transformation or elec-
troporation was not successful. Thus, the involvement of un-
known mutations in the enhanced resistance in CR3e cannot
be totally excluded at this stage.
The expression of MDR efflux pumps can be conditionally
induced by structurally diverse substrates of these pumps (1, 5,
12, 22, 23, 28, 29, 41). This induction is due to the direct in-
teraction of the substrates with repressor molecules, which
interferes with the binding of repressors to operator DNA and
which results in increased levels of expression of MDR pump
genes. Transcriptional regulators of the TetR family are char-
acterized by a conserved HTH-containing DNA-binding do-
main at the N-terminal region and a divergent C-terminal
sequence that is involved in the binding to inducing com-
pounds (12, 19, 20). The variation in the C-terminal sequence
reflects the diversity of substrates that can interact with the
regulators. A conformational change occurs in the DNA-bind-
ing domain when an inducer binds to the C-terminal region of
a repressor, releasing the inhibition to efflux pumps. Although
CmeABC is the key pump for bile resistance in Campylobacter
(25), no differences in the MICs of cholic acid and choleate
were observed for the wild-type strain 81-176 and strain JL107
(an isogenic cmeR mutant of strain 81-176) (Table 4). Consid-
ering the fact that bile salts induce AcrAB expression in E. coli
(41), it is possible that bile salts also induce cmeABC expres-
sion in Campylobacter. If this induction indeed occurs, it would
obscure the differences in the MICs of bile salts for wild-type
strain 81-176 and the CmeR mutant due to the enhanced
expression of cmeABC in strain 81-176 in the presence of bile
salts. At this stage, it is unclear if the expression of cmeABC is
inducible and if any substrates directly interact with CmeR.
Since we have constructed the transcriptional reporter system
(PcmeABC-lacZ) and established the gel mobility shift assay using
rCmeR, the induction of cmeABC under various conditions
can now be examined in a definitive manner.
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